Semaglutide in Australia: A Doctor’s Practical Review for People Over 30
Written from a clinical perspective for Australian adults who want lasting metabolic change, not another failed quick fix.
Attention: The “After 30” Struggle Is Real
If you are over 30, you may have noticed something frustrating: the same diet that worked at 25 no longer works. Weight settles around your waist, energy dips after meals, blood pressure creeps up, and your doctor mentions “borderline” blood sugar or fatty liver. You feel tired, heavy, and sometimes judged — as if you simply lack willpower.
As a doctor, I see this daily. Patients tell me they have tried keto, intermittent fasting, low-calorie shakes, personal trainers, meal plans. They lose a few kilos, then regain more. The problem is rarely effort. It is biology: appetite hormones, insulin resistance, and a body that defends a higher weight set point. This is where semaglutide changes the conversation.
Interest: What Makes Semaglutide Different?
Semaglutide is a GLP-1 receptor agonist, originally developed for type 2 diabetes and now TGA-approved in Australia for chronic weight management. It is not a stimulant and it is not an old-school appetite suppressant. Semaglutide mimics a natural gut hormone called GLP-1 that is released after eating. It helps your brain recognise fullness sooner, slows stomach emptying, reduces cravings, and improves how your body responds to insulin.
In clinical trials, people using semaglutide 2.4 mg once weekly achieved an average weight loss of around 15% of their body weight when combined with a reduced-calorie diet and increased physical activity. For a 100 kg person, that is about 15 kg. More importantly, many patients see improvements in waist circumference, blood pressure, fasting glucose, liver enzymes, and joint pain.
| Brand | Active ingredient | Typical indication | PBS status in Australia |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | PBS-subsidised for eligible patients with type 2 diabetes |
| Wegovy | Semaglutide | Obesity / overweight with weight-related complications | Generally private prescription; ask your GP about current availability and cost |
Desire: Addressing the Real Questions Australian Patients Ask
Semaglutide and aerobic exercise
Semaglutide is not a replacement for movement, but it makes exercise easier and more rewarding. Many patients over 30 avoid aerobic exercise because knee pain, breathlessness, and low confidence make it unpleasant. As semaglutide reduces body weight and inflammation, walking, cycling, swimming, or even climbing stairs becomes less painful. Aerobic exercise also helps preserve lean muscle during weight loss, improves mood, and supports long-term heart health.
In practice, I recommend starting with 150 minutes of moderate aerobic activity per week. This can be as simple as 30 minutes of brisk walking five days per week. Semaglutide may reduce your appetite so much that you under-fuel exercise; a dietitian can help you maintain energy and muscle.
Semaglutide allergy symptoms
True allergy to semaglutide is rare, but you must know the warning signs. Stop the medication and seek urgent medical care if you develop a widespread rash, hives, swelling of the lips, tongue, face or throat, difficulty breathing, severe dizziness, or intense abdominal pain with repeated vomiting. These can indicate a serious allergic or pancreatic reaction.
Milder symptoms such as temporary nausea, bloating, or a mild injection-site reaction are common in the first weeks and usually settle as the body adjusts. Never ignore difficulty breathing or facial swelling.
Semaglutide and liver function
Many Australians over 30 carry excess fat around the liver — non-alcoholic fatty liver disease. This is often invisible on routine blood tests until ALT or GGT start to rise. Semaglutide can reduce liver fat, improve liver enzyme levels, and lower cardiovascular risk in people with fatty liver and insulin resistance.
Before starting, your doctor may arrange liver function tests. If you have active gallbladder disease, gallstones, or severe liver impairment, dose adjustment or specialist advice may be required. For most patients, improving body weight and blood glucose is one of the best things you can do for your liver.
Switching from other GLP-1 agonists to semaglutide
If you have used liraglutide (Saxenda/Victoza), dulaglutide (Trulicity), or another GLP-1 agonist, do not simply take semaglutide at the same “high” dose. Semaglutide must be restarted at a low dose and titrated up, even if your previous medication was working.
| Current medicine | Suggested switching approach |
|---|---|
| Daily liraglutide (Saxenda/Victoza) | Stop the daily injection the day before; start semaglutide 0.25 mg once weekly on the agreed day |
| Weekly dulaglutide (Trulicity) | Do not take the next dulaglutide dose; start semaglutide 0.25 mg on the day that injection would have been due |
| Any GLP-1 already at a high dose | Restart semaglutide at 0.25 mg weekly and titrate slowly — never transfer at an equivalent high dose |
Semaglutide and hormonal therapy
Hormonal changes after 30 — perimenopause, menopause, polycystic ovary syndrome, thyroid conditions, testosterone replacement — can make weight loss feel impossible. Semaglutide may improve insulin sensitivity and help overcome the metabolic resistance that hormonal changes create. There is no major direct interaction between semaglutide and most hormonal therapies, but because semaglutide slows stomach emptying, the absorption of some oral hormones may change.
If you use oral hormone therapy, thyroid medication, or an oral contraceptive, your doctor may advise taking these medications at a different time from food or monitor levels more closely in the first months. Weight loss itself may also change hormone levels, so regular review is essential.
Semaglutide and maintenance therapy after weight loss
One of the biggest mistakes is stopping semaglutide the moment the scale reaches your goal. Obesity is a chronic condition, and the body defends its previous weight set point. Studies show that stopping semaglutide often leads to gradual weight regain because appetite and cravings return.
Maintenance therapy usually means continuing the effective dose long-term. Some patients can step down to a lower maintenance dose under medical supervision, but most need ongoing treatment at 1.0 mg, 1.7 mg, or 2.4 mg weekly to keep the benefits. Think of it like blood pressure medication: you continue it to keep the condition controlled.
How to titrate semaglutide dose
Titration is the process of gradually increasing the dose to reduce nausea and other stomach side effects. Semaglutide is injected once weekly, on the same day each week, with or without food.
| Time period | Weekly dose | Purpose |
|---|---|---|
| Weeks 1–4 | 0.25 mg | Starting dose to allow your body to adjust |
| Weeks 5–8 | 0.5 mg | First step up; some diabetes patients may stay here temporarily |
| Weeks 9–12 | 1.0 mg | Common diabetes maintenance dose; further weight-loss titration continues if needed |
| Weeks 13–16 | 1.7 mg | Weight-management step for Wegovy |
| Week 17 onward | 2.4 mg | Standard weight-management maintenance dose if tolerated |
Never skip titration to “get faster results.” Rapid dose increases cause more nausea, vomiting, and treatment dropout. Most patients tolerate the schedule well when they eat smaller, lower-fat meals and avoid heavy alcohol.
Semaglutide patient assistance programs in Australia
Cost is a legitimate concern. If you have type 2 diabetes and meet PBS criteria, Ozempic may be subsidised, significantly reducing your out-of-pocket cost. For weight management, Wegovy is generally available on private prescription, and the monthly cost varies between pharmacies. Some private health funds may offer extras cover, but this is not guaranteed.
You may be eligible for manufacturer support programs or pharmacy-based injection coaching. Ask your GP or pharmacist about current Novo Nordisk patient support offerings in Australia. Avoid unregistered compounded semaglutide products sold online — the TGA has warned about safety, quality, and incorrect dosing with some compounded versions. Use only TGA-approved medication prescribed by a registered Australian doctor.
Action: Your Next Step
If you recognise yourself in this article — tired of rebound weight, worried about diabetes, embarrassed by fatty liver, frustrated by hormonal changes — then semaglutide may be the missing tool in your medical care. It is not a magic injection, but it is one of the most effective evidence-based treatments we have for sustainable weight loss and metabolic improvement.
Book an appointment with your Australian GP. Ask about TGA-approved semaglutide, check your eligibility for PBS or private prescription, review your liver function and blood tests, and build a plan that includes aerobic exercise, nutrition support, and long-term maintenance. Many patients tell me they wish they had started sooner.
Take control of your metabolic health today — talk to your doctor about whether semaglutide is right for you.
Disclaimer: This article is for educational purposes only and does not replace individual medical advice. Semaglutide is a prescription-only medicine. Side effects, contraindications, and PBS eligibility vary. Always consult a registered medical practitioner before starting or changing treatment.
